CN101208599B - 用于涂覆通过亲和力-测定法用于被分析物检测的底物基质的新的设备和方法 - Google Patents
用于涂覆通过亲和力-测定法用于被分析物检测的底物基质的新的设备和方法 Download PDFInfo
- Publication number
- CN101208599B CN101208599B CN200680023014.9A CN200680023014A CN101208599B CN 101208599 B CN101208599 B CN 101208599B CN 200680023014 A CN200680023014 A CN 200680023014A CN 101208599 B CN101208599 B CN 101208599B
- Authority
- CN
- China
- Prior art keywords
- substrates
- liquid
- equipment
- atomized
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000758 substrate Substances 0.000 title claims abstract description 246
- 238000000034 method Methods 0.000 title claims abstract description 166
- 238000000576 coating method Methods 0.000 title claims abstract description 103
- 239000011248 coating agent Substances 0.000 title claims abstract description 80
- 238000001514 detection method Methods 0.000 title claims abstract description 41
- 239000012491 analyte Substances 0.000 title claims description 46
- 238000003556 assay Methods 0.000 title abstract description 4
- 239000007788 liquid Substances 0.000 claims abstract description 133
- 238000002161 passivation Methods 0.000 claims abstract description 40
- 150000001875 compounds Chemical class 0.000 claims abstract description 30
- 238000000889 atomisation Methods 0.000 claims abstract description 25
- 239000000126 substance Substances 0.000 claims abstract description 11
- 239000003595 mist Substances 0.000 claims description 44
- 230000027455 binding Effects 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 17
- 238000010422 painting Methods 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 17
- 239000011521 glass Substances 0.000 claims description 14
- 230000001276 controlling effect Effects 0.000 claims description 13
- 230000008859 change Effects 0.000 claims description 10
- 238000007306 functionalization reaction Methods 0.000 claims description 9
- 229920001577 copolymer Polymers 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 8
- 108010088751 Albumins Proteins 0.000 claims description 7
- 102000009027 Albumins Human genes 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- 125000005600 alkyl phosphonate group Chemical group 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 239000010695 polyglycol Substances 0.000 claims description 6
- 229920000151 polyglycol Polymers 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical group [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 5
- 229910000077 silane Inorganic materials 0.000 claims description 5
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000005018 casein Substances 0.000 claims description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000006199 nebulizer Substances 0.000 claims description 4
- 238000009423 ventilation Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 3
- 150000002118 epoxides Chemical class 0.000 claims description 3
- 238000001764 infiltration Methods 0.000 claims description 3
- 230000008595 infiltration Effects 0.000 claims description 3
- 229920006112 polar polymer Polymers 0.000 claims description 3
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims description 2
- 230000008021 deposition Effects 0.000 claims description 2
- 230000000670 limiting effect Effects 0.000 claims description 2
- 239000012466 permeate Substances 0.000 claims description 2
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 claims description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 53
- 230000003287 optical effect Effects 0.000 description 49
- 239000000523 sample Substances 0.000 description 29
- 238000001802 infusion Methods 0.000 description 21
- 239000007789 gas Substances 0.000 description 20
- 239000013592 cell lysate Substances 0.000 description 16
- 230000002349 favourable effect Effects 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- 239000010408 film Substances 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 10
- 238000010276 construction Methods 0.000 description 10
- 230000008878 coupling Effects 0.000 description 10
- 238000010168 coupling process Methods 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 238000005253 cladding Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000009870 specific binding Effects 0.000 description 7
- 239000004793 Polystyrene Substances 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 230000009871 nonspecific binding Effects 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 229920002223 polystyrene Polymers 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 238000013016 damping Methods 0.000 description 5
- 229960004679 doxorubicin Drugs 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 230000026731 phosphorylation Effects 0.000 description 5
- 238000006366 phosphorylation reaction Methods 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 4
- 239000004642 Polyimide Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 208000013715 atelosteogenesis type I Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000013068 control sample Substances 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 238000001746 injection moulding Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 239000012788 optical film Substances 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 229920001721 polyimide Polymers 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- 239000010453 quartz Substances 0.000 description 4
- 230000011664 signaling Effects 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 4
- 229920006352 transparent thermoplastic Polymers 0.000 description 4
- 241000972773 Aulopiformes Species 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
- 241001275898 Mylopharyngodon piceus Species 0.000 description 3
- 229910010413 TiO 2 Inorganic materials 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QZRMKGRPCTVXBS-UHFFFAOYSA-N 2,6,8-trimethylnonan-4-yl dihydrogen phosphate Chemical compound CC(C)CC(C)CC(CC(C)C)OP(O)(O)=O QZRMKGRPCTVXBS-UHFFFAOYSA-N 0.000 description 2
- 230000005778 DNA damage Effects 0.000 description 2
- 231100000277 DNA damage Toxicity 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 229910052581 Si3N4 Inorganic materials 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000002520 cambial effect Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000003501 hydroponics Substances 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 238000006424 Flood reaction Methods 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 108091093078 Pyrimidine dimer Proteins 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 102100035712 Serrate RNA effector molecule homolog Human genes 0.000 description 1
- 108010036039 Serrate-Jagged Proteins Proteins 0.000 description 1
- 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 1
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- ASJWEHCPLGMOJE-LJMGSBPFSA-N ac1l3rvh Chemical compound N1C(=O)NC(=O)[C@@]2(C)[C@@]3(C)C(=O)NC(=O)N[C@H]3[C@H]21 ASJWEHCPLGMOJE-LJMGSBPFSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000010327 methods by industry Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000004375 physisorption Methods 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B17/00—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups
- B05B17/04—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods
- B05B17/06—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations
- B05B17/0607—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers
- B05B17/0615—Apparatus for spraying or atomising liquids or other fluent materials, not covered by the preceding groups operating with special methods using ultrasonic or other kinds of vibrations generated by electrical means, e.g. piezoelectric transducers spray being produced at the free surface of the liquid or other fluent material in a container and subjected to the vibrations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
Landscapes
- Health & Medical Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Sampling And Sample Adjustment (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH0735/05 | 2005-04-26 | ||
| CH7352005 | 2005-04-26 | ||
| PCT/EP2006/003726 WO2006114249A1 (de) | 2005-04-26 | 2006-04-22 | Neue apparatur und verfahren zur beschichtung von trägersubstraten für einen analytnachweis mittels affinitäts-nachweisverfahren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101208599A CN101208599A (zh) | 2008-06-25 |
| CN101208599B true CN101208599B (zh) | 2014-12-10 |
Family
ID=36808724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200680023014.9A Expired - Fee Related CN101208599B (zh) | 2005-04-26 | 2006-04-22 | 用于涂覆通过亲和力-测定法用于被分析物检测的底物基质的新的设备和方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9050615B2 (enExample) |
| EP (1) | EP1877773B1 (enExample) |
| JP (1) | JP5002584B2 (enExample) |
| CN (1) | CN101208599B (enExample) |
| AU (1) | AU2006239534B2 (enExample) |
| CA (1) | CA2605750A1 (enExample) |
| DK (1) | DK1877773T3 (enExample) |
| ES (1) | ES2525324T3 (enExample) |
| WO (1) | WO2006114249A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2485564A (en) * | 2010-11-18 | 2012-05-23 | Rolls Royce Plc | Luminescent surface coating for inspection |
| WO2013001431A1 (en) | 2011-06-30 | 2013-01-03 | Koninklijke Philips Electronics N.V. | Multiple examinations of a sample |
| JP6384491B2 (ja) | 2014-01-10 | 2018-09-05 | コニカミノルタ株式会社 | イムノアッセイ法およびイムノアッセイシステム |
| DE102014112625A1 (de) * | 2014-09-02 | 2016-03-03 | Schmid Energy Systems Gmbh | Großflächen-Ultraschallverdampfer |
| EP3229977A4 (en) * | 2014-12-08 | 2019-02-27 | University of Virginia Patent Foundation, D/B/A University of Virginia | COMPOSITIONS AND METHODS FOR BONDING ADHESIVES, FABRICS AND COATINGS ON SURFACES |
| CH712376A1 (de) | 2016-04-19 | 2017-10-31 | Camag | Derivatisierungsgerät und -verfahren. |
| CN106198952A (zh) * | 2016-07-01 | 2016-12-07 | 清华大学 | 一种抑制核酸分子对传感界面非特异性吸附的封闭方法 |
| CN107807133A (zh) * | 2017-11-08 | 2018-03-16 | 苏州安路特汽车部件有限公司 | 一种雾化渗透探伤装置 |
| EP3963091A4 (en) * | 2019-04-29 | 2023-07-19 | Nautilus Biotechnology, Inc. | METHODS AND SYSTEMS FOR ON-CHIP INTEGRATED SINGLE MOLECULE DETECTION |
| CN115147617B (zh) * | 2022-09-06 | 2022-11-22 | 聊城集众环保科技有限公司 | 基于计算机视觉的污水处理智能监控方法 |
| CN115837944A (zh) * | 2023-02-16 | 2023-03-24 | 太原理工大学 | 一种电厂烟气注入采空区防灾封存的气体监测装置 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0486393A1 (fr) * | 1990-11-16 | 1992-05-20 | Centre National De La Recherche Scientifique | Procédé sol-gel de dépôt de couches minces par pulvérisation ultrasonore |
| EP0614055B1 (en) * | 1993-03-04 | 1997-08-06 | Mario Bonzi | Device for humidifying and ionizing air |
| WO2004099430A2 (de) * | 2003-05-06 | 2004-11-18 | Friz Biochem Gesellschaft Für Bioanalytik Mbh | Substrat als träger von ligaten |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3514847A (en) * | 1966-05-10 | 1970-06-02 | Gen Dynamics Corp | Process for making photoconductive matrices |
| WO1984001031A1 (en) | 1982-08-27 | 1984-03-15 | Roger Philip Ekins | Measurement of analyte concentration |
| JPS5955367A (ja) * | 1982-09-21 | 1984-03-30 | Tdk Corp | 静電防止剤塗布装置 |
| JPS6146028A (ja) * | 1984-08-10 | 1986-03-06 | Fujitsu Ltd | レジスト塗布装置 |
| US5807755A (en) | 1987-08-06 | 1998-09-15 | Multilyte Limited | Determination of ambient concentrations of several analytes |
| GB8803000D0 (en) | 1988-02-10 | 1988-03-09 | Ekins Roger Philip | Determination of ambient concentrations of several analytes |
| JPH01115450A (ja) * | 1987-10-28 | 1989-05-08 | Seiko Epson Corp | 潤滑層の形成方法 |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| JPH03296460A (ja) * | 1990-04-13 | 1991-12-27 | Fujitsu General Ltd | フラックス塗付装置 |
| EP1122539A3 (en) * | 1991-02-11 | 2001-11-07 | Biostar, Inc. | Method for production of a test surface for use in optical detection of a biological binding event |
| JPH06134367A (ja) * | 1992-04-10 | 1994-05-17 | Murata Mfg Co Ltd | 電子部品の外装構造 |
| GB9326450D0 (en) | 1993-12-24 | 1994-02-23 | Multilyte Ltd | Binding assay |
| PL317379A1 (en) | 1994-05-27 | 1997-04-01 | Ciba Geigy Ag | Supercritically excited luminescence detecting process |
| EP1890130A3 (en) | 1995-05-12 | 2008-02-27 | Novartis AG | Sensor platform for the parallel detection of a plurality of analytes using evanescently excited luminescenes |
| WO1997002856A1 (en) * | 1995-07-10 | 1997-01-30 | A & D Company, Limited | Handy atomizer |
| KR0144065B1 (ko) * | 1995-08-30 | 1998-08-01 | 배순훈 | 히터식 초음파 가습기 |
| US6143063A (en) * | 1996-03-04 | 2000-11-07 | Symetrix Corporation | Misted precursor deposition apparatus and method with improved mist and mist flow |
| WO1998009156A1 (en) | 1996-08-29 | 1998-03-05 | Novartis Ag | Optical chemical / biochemical sensor |
| US6045864A (en) * | 1997-12-01 | 2000-04-04 | 3M Innovative Properties Company | Vapor coating method |
| US6406921B1 (en) | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| WO2000065352A1 (en) | 1999-04-28 | 2000-11-02 | Eidgenossisch Technische Hochschule Zurich | Polyionic coatings in analytic and sensor devices |
| CN1371303A (zh) * | 1999-08-27 | 2002-09-25 | 皮科格瑞姆公司 | 在带电微单元上进行操作的方法及装置 |
| US6510263B1 (en) | 2000-01-27 | 2003-01-21 | Unaxis Balzers Aktiengesellschaft | Waveguide plate and process for its production and microtitre plate |
| AU2001234739A1 (en) | 2000-02-02 | 2001-08-14 | Cartesian Technologies, Inc. | Method and apparatus for developing dna microarrays |
| AU2001262178A1 (en) | 2000-04-14 | 2001-10-30 | Zeptosens Ag | Grid-waveguide structure for reinforcing an excitation field and use thereof |
| US20030138208A1 (en) | 2000-05-06 | 2003-07-24 | Michael Pawlak | Grating optical waveguide structure for multi-analyte determinations and the use thereof |
| US7879598B2 (en) | 2000-09-04 | 2011-02-01 | Bayer Technology Services Gmbh | Multianalyte determination system and methods |
| AU2002257671A1 (en) | 2001-04-02 | 2002-10-15 | Zeptosens Ag | Optical structure for multi-photon excitation and the use thereof |
| WO2003050517A1 (de) | 2001-12-13 | 2003-06-19 | Zeptosens Ag | Optisch transparentes trägersubstrat für eine maldi-messanordnung und dessen verwendung |
| WO2004023142A1 (de) | 2002-09-03 | 2004-03-18 | Zeptosens Ag | Analytische plattform und nachweisverfahren mit den in einer probe nachzuweisenden analyten als immobilisierten spezifischen bindungspartnern |
| JP4318978B2 (ja) * | 2003-07-29 | 2009-08-26 | 独立行政法人科学技術振興機構 | 高分子固定化基板の製造方法およびこの方法により得られる高分子固定化基板 |
-
2006
- 2006-04-22 US US11/919,054 patent/US9050615B2/en not_active Expired - Fee Related
- 2006-04-22 EP EP06724515.9A patent/EP1877773B1/de not_active Not-in-force
- 2006-04-22 WO PCT/EP2006/003726 patent/WO2006114249A1/de not_active Ceased
- 2006-04-22 JP JP2008508125A patent/JP5002584B2/ja not_active Expired - Fee Related
- 2006-04-22 CN CN200680023014.9A patent/CN101208599B/zh not_active Expired - Fee Related
- 2006-04-22 CA CA002605750A patent/CA2605750A1/en not_active Abandoned
- 2006-04-22 ES ES06724515.9T patent/ES2525324T3/es active Active
- 2006-04-22 AU AU2006239534A patent/AU2006239534B2/en not_active Ceased
- 2006-04-22 DK DK06724515.9T patent/DK1877773T3/en active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0486393A1 (fr) * | 1990-11-16 | 1992-05-20 | Centre National De La Recherche Scientifique | Procédé sol-gel de dépôt de couches minces par pulvérisation ultrasonore |
| EP0614055B1 (en) * | 1993-03-04 | 1997-08-06 | Mario Bonzi | Device for humidifying and ionizing air |
| WO2004099430A2 (de) * | 2003-05-06 | 2004-11-18 | Friz Biochem Gesellschaft Für Bioanalytik Mbh | Substrat als träger von ligaten |
Non-Patent Citations (3)
| Title |
|---|
| JP平1-115450A 1989.05.08 * |
| JP平3-296460A 1991.12.27 * |
| JP特开平6-134367A 1994.05.17 * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006239534A1 (en) | 2006-11-02 |
| EP1877773B1 (de) | 2014-10-15 |
| JP5002584B2 (ja) | 2012-08-15 |
| US9050615B2 (en) | 2015-06-09 |
| AU2006239534B2 (en) | 2012-05-31 |
| US20090311773A1 (en) | 2009-12-17 |
| WO2006114249A1 (de) | 2006-11-02 |
| CN101208599A (zh) | 2008-06-25 |
| DK1877773T3 (en) | 2015-01-19 |
| EP1877773A1 (de) | 2008-01-16 |
| JP2008539399A (ja) | 2008-11-13 |
| ES2525324T3 (es) | 2014-12-22 |
| CA2605750A1 (en) | 2006-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101715552B (zh) | 用于处理液滴中样品的仪器及其使用方法 | |
| DE60003171T2 (de) | Methoden zur miniaturisierten zellenanordnung und auf zellen basierendes screening gerät | |
| Shumaker-Parry et al. | Microspotting streptavidin and double-stranded DNA arrays on gold for high-throughput studies of protein− DNA interactions by surface plasmon resonance microscopy | |
| US7476510B2 (en) | Miniaturized cell array methods and apparatus for cell-based screening | |
| AU2013207599B2 (en) | Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof | |
| CN101208599B (zh) | 用于涂覆通过亲和力-测定法用于被分析物检测的底物基质的新的设备和方法 | |
| JP2004510130A5 (enExample) | ||
| CN1954213A (zh) | 用于产生细胞群体的蛋白表达谱的分析平台和方法 | |
| EP1274986A1 (de) | Vorrichtung und verfahren zur multianalytbestimmung | |
| JP2005537487A (ja) | 試料中において任意には分画された後の試料中において、固定化特異的結合パートナーとして測定される分析対象物を用いる分析プラットフォーム及び検出法 | |
| JP2007526460A5 (enExample) | ||
| JP2012013549A (ja) | 粒子固定用構造体、粒子解析装置、及び解析方法 | |
| JP2005537486A (ja) | 分析対象物が試料中で固定化された特異的結合パートナーとして測定される分析プラットフォーム及び検出法 | |
| JP2012013550A (ja) | 粒子固定用構造体、粒子解析装置、及び解析方法 | |
| US20230250376A1 (en) | Device and method for cell cultivation | |
| Weschenfelder et al. | The stripe assay: studying growth preference and axon guidance on binary choice substrates in vitro | |
| US20200129978A1 (en) | Devices and methods for flow control using electro-osmotic flow | |
| EP1655363A1 (en) | Cell microchip | |
| MXPA01002960A (en) | Miniaturized cell array methods and apparatus for cell-based screening |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH Free format text: FORMER OWNER: BAYER AG Effective date: 20130830 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20130830 Address after: German Monheim Applicant after: Bayer Pharma Aktiengesellschaft Address before: Germany Leverkusen Applicant before: Bayer Ag |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141210 Termination date: 20170422 |